Content

National Guidance for AI in Mental and Substance Use Health Care

Body

In a first-of-its-kind initiative, national guidance for using artificial intelligence (AI) in the mental and substance use health (MHSUH) field is being developed through a partnership between the Canadian Centre on Substance Use and Addiction (CCSA) and the Mental Health Commission of Canada (the Commission).

Body

AI is increasingly being used for healthcare triage, service navigation, service delivery, and communication, but service providers, developers and users have no guidelines specific to mental or substance use health to support its effective and safe use. The recently published E-Mental Health Strategy for Canada highlights the need for safety in this field. 

The new National Guidance for Artificial Intelligence Use in Mental Health and Substance Use Health Care will provide guidance, tools, and resources to help practitioners, organizations, and health leaders in efficiently evaluating and implementing AI-enabled mental health and substance use health care services and solutions. 

It will also support people with lived or living experience of mental health or substance use health concerns in making informed choices about these technologies, while helping technology companies design and improve such solutions to meet the needs of those who use them. The full guidance will launch in 2026/2027.

Body

Early Findings

Through our literature review and environmental scan, we identified 10 key considerations for early guidance, along three main themes: equity, privacy and governance, human-centred care, and trust and explainability. We will refine these findings through engagement with expert advisory groups to ensure the final guidance reflects the unique considerations within the MHSUH sectors.

See our one-page summary for details. 

By investing early in national guidance, Canada is positioning itself as a global leader in ensuring that technological innovation in healthcare translates into safer, more equitable outcomes.

Image
Early findings of the National Guidance for AI in Mental and Substance Use Health Care

Body

Steering Committee 

Heading
Dr. Allison Crawford, MD, PhD

Body

Chief Medical Officer, 9-8-8 Suicide Crisis Helpline
Professor Departments of Psychiatry and Dalla Lana School of Public Health, University of Toronto
Psychiatrist, Centre for Addiction and Mental Health

Heading
Ben Rosen

Body

Psychiatrist, (Physician Lead, Psychiatry Emergency Services), Sinai Health
Medical Head, Psychiatry Partnerships with Northern Communities, Centre for Addiction and Mental Health
Associate Professor, Faculty of Medicine, Department of Psychiatry, University of Toronto

Heading
Carly Straker

Body

Manager, System Quality and Integration, Mental Wellness and Addictions Recovery Division, Government of the Northwest Territories

Heading
Dr. Christopher DiCarlo

Body

Principal/Founder, Critical Thinking Solutions

Heading
David Martell

Body

Physician Lead, Addiction Medicine – Mental Health & Addictions Program, Nova Scotia Health

Heading
Gillian Strudwick

Body

Scientific Director, Registered Nurse, Centre for Addiction and Mental Health
 

Heading
Jeannie Borg RN, MA Leadership

Body

Director of Clinical Informatics and Digital Health, Waypoint Centre for Mental Health Care
 

Heading
Jonathan Morris

Body

CEO, Canadian Mental Health Association BC Division
 

Heading
Rebecca Jesseman

Body

Executive Director, Mental Health and Addictions, Health PEI
 

Heading
Russell Greiner

Body

Professor, Department of Computing Science, University of Alberta
Adjunct Professor, Department of Psychiatry, University of Alberta
Canada CIFAR AI Chair and Fellow-in-Residence, Alberta Machine Intelligence Institute (Amii)

Heading
Valerie Pisano

Body

President & CEO, MILA
 

Body

Sign up below: 

Webform

Join the Waitlist

Sign up to be notified of early findings!

Name
Contact Info
I understand that the personal information I provide on this form is being collected for the purpose of notifying me when I can access National Guidance for Artificial Intelligence Use with Mental Health and Substance Use Health and that my personal information will be protected under the CCSA Website Privacy Notice.